These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 160627)

  • 1. Inhibition of plasminogen activator associated with chronic granulomatous inflammation.
    Goldstein SM; Izaki S; Epstein WL
    Thromb Res; 1979; 16(5-6):727-35. PubMed ID: 160627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
    Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
    [No Abstract]   [Full Text] [Related]  

  • 3. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA; Anderson JA; Bennett B
    Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a partially purified preparation of a circulating plasminogen activator.
    Ogston D; Bennett B; Mackie M
    Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of the polyphenols of cider on plasmin and plasminogen activators.
    Ogston D; Lea AG; Langhorne P; Wilson SB
    Br J Haematol; 1985 Aug; 60(4):705-13. PubMed ID: 3161536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
    Ogston D
    Acta Haematol; 1982; 67(2):114-8. PubMed ID: 6801892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
    Lijnen HR; Collen D
    Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318
    [No Abstract]   [Full Text] [Related]  

  • 11. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
    Reboud-Ravaux M; Vilain AC; Boggetto N; Maillard J; Favreau C; Xie J; Mazaleyrat JP; Wakselman M
    Biochem Biophys Res Commun; 1991 Jul; 178(1):352-9. PubMed ID: 1829886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of the fibrinolytic antiactivator by substituted benzoates.
    Nanninga L; Guest M
    Life Sci; 1974 Jun; 14(12):2507-11. PubMed ID: 4283613
    [No Abstract]   [Full Text] [Related]  

  • 15. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on human activators of plasminogen.
    Mackie M; Booth NA; Bennett B
    Br J Haematol; 1981 Jan; 47(1):77-90. PubMed ID: 6449216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on interactions between plasminogen activator-containing fluids and avain and murine lymphocytes.
    Wainberg MA; Cohen SD
    Dev Comp Immunol; 1981; 5(4):649-60. PubMed ID: 6274714
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor.
    Lecander I; Roblin R; Astedt B
    Br J Haematol; 1984 Jul; 57(3):407-12. PubMed ID: 6430331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.